Saliva Drug Test ORAL·SCREEN™ is the world's first oral fluid (saliva) based, point of contact test screen for illicit and prescription drug use or abuse. Simple and discreet drug of abuse testing without the inconvenience, embarrassment or biological hazard risks associated with urine specimen collection and handling. Completely eliminates the possibility of sample contamination, adulteration, substitution or manipulation. For Forensic Use Only.

Saliva Drug tests also available in 5 Panel 6 Panel

PRINCIPLE

Now Available! OralScreen OSR automated test interpretation and recording system

Incorporating a newly developed, patented collection device for human saliva samples, the ORAL·SCREEN™ is a self-contained, ready to use, point of contact drug testing device that detects four drugs (or drug classes) of abuse: Marijuana (THC), Cocaine, Opiates (or all opium based drugs) and Methamphetamine (and its derivatives) using the preferred lateral flow immunoassay technology for this method of test screening. The test requires no special training to complete and qualitative yes/no results are visibly obtained within several minutes.

Oral Fluid Assay System For Drugs of Abuse

The ORAL·SCREEN™ forensic drug testing system detects the four most commonly abused illicit drugs using a saliva sample. Because urine collection is not necessary, there are certain advantages using the ORAL·SCREEN™ system for on-site drug screening. Additionally, because the test subject is present for the entire sample collection and  testing process, the possibility of sample adulteration and/or substitution is eliminated. The ORAL·SCREEN™ will detect Marijuana (THC), Cocaine (COC), Opiate (OPI) and Methamphetamine (M-AMP) use at a sensitivity level for saliva concentration* according to the following chart:

* Sensitivity detection levels for oral fluid (saliva) are considerably lower than those for urine tests because the concentration of detectable drug metabolites are significantly less in oral fluids (saliva). The sensitivity cut-off levels above generally correlate with the standards established for forensic urine tests by the NIDA, SAMSHA and WHO. For a technical document on the precision and specificity of the OralScreen saliva drug screen in relationship to urine based tests see the OralScreen Technical Whitepaper. 

Additionally, the ORAL-SCREEN drug test will detect the  metabolites and chemical derivatives of the class of drugs noted above including all opium derivatives (codeine, heroin, etc.) and Methamphetamine (ecstasy, amphetamine, etc.) Other features of using the ORAL·SCREEN™ drug test include:

PROCEDURE:

The ORAL·SCREEN™ System is formulated for use with human oral fluid speci­mens (saliva). Confirm the expiration date printed on the test package. Do not open the test package until you are ready to perform the drug screen assay. If, necessary, bring the test pouch to room temperature . Insure that the person being tested has had nothing in their mouth for at least 5 minutes before sample collection. This includes water or other beverages (dilution) or food of any type (contamination). Directly observe the person during sample collection.

1. Collect the oral fluid sample by removing the collector swab device from the package, sliding the plastic hood back and exposing the absorbent foam. Do not touch or otherwise allow any objects or materials to come in contact e with the exposed foam portion of the swab collection device. Use the handle or plastic hood of the swab to manipulate the swab during sample collection.

2. Have the person pucker their mouth and accumulate oral fluid before inserting the swab collector. The process is the same as accumulating saliva in the mouth prior to spitting. Immediately place the foam end of the swab in the subject's mouth and move the foam around gently for at least 2 minutes to allow the oral fluid to saturate the foam. Requesting the subject to press gently with their tongue may help the oral fluid to saturate the collector foam. The test subject should be instructed not chew or suck on the collector during the collection process.

3. Remove the collector and hold it in a slightly vertical position with the foam end up at a 30-45 degree angle. Do not hold the swab straight up (90 degrees). Slide the hood forward gently until you just begin to see oral fluid on the surface of the foam. 

4. With one hand, hold the hood in place over the foam and squeeze both the foam and the end of the hood between your fin­gers. Tip the collector downwards and add four to five (4-5) individual drops of oral fluid into the sample well of the test cassette waiting at least ten (10) seconds between each drop. Allow each drop to soak into the sample well pad before applying the next drop. In the case of very viscous samples, you may apply the 4th drop on top of the 3rd drop when the 3rd drop has almost sunk all the way into the sample pad. Do not overfill the sample well, however add enough sample that visible sample migration across the test result panel occurs.

INTERPRETATION OF RESULTS

Wait 15 minutes for test results to fully develop. Test results are read by observing and scoring the pre-printed red/pink lines on the test result panel as present or absent, 15 minutes after the sample was added:

NEGATIVE	POSITIVE M-AMP	POSITIVE THC/M-AMP	INVALID
A Negative test result is indicated by pink rose lines adjacent to each target drug label plus a control line.	A Positive test result is indicated by the absence of a pink rose line adjacent to the target drug label plus a control line.	A Positive multiple test result is indicated by the absence of pink rose lines adjacent to each target drug label plus a control line.	An Invalid test result is indicated by the absence of a pink rose line adjacent to the "C" or Control label regardless of results in the other labeled areas.

A NEGATIVE test result is indicated by the continued presence of a red/pink line adjacent to the labeled target drug.. If there remains a visible line, no matter how faint it may become during test development, the test should be considered negative for the target drug. An extremely faint line could mean that the target drug is near the sensitivity cut-off level for the test. In such circumstances the test could be repeated at another time or a more quantitative method of laboratory testing be employed.
A POSITIVE test result is indicated by the complete absence of a red/pink line at the position indicated for the drug in the test panel. More than one line may be absent indicating a multiple positive drug screen.
An INVALID test result is indicated by the absence of a red/pink line at the (C) or control position.

INTERACTIVE TRAINING PROGRAM AND TECHNICAL BULLETIN

For a comprehensive discussion on drug of abuse testing including typical detection time periods see the DRUG TESTING FAQ

A comprehensive interactive training program on using the ORAL·SCREEN™ Saliva Drug Testing System is available for download. This program covers proper use of the testing devices in detail including sample collection and handling, test procedure, interpretation of test results and confirmation of positive results. We recommend this program be used as a training reference for all saliva based drug testing programs. The ORAL·SCREEN™ training program requires Flash Player™ from www.macromedia.com to run properly. Download the Interactive Training Program. For a technical document on the precision and specificity of the OralScreen saliva drug screen in relationship to urine based tests see the OralScreen Technical Whitepaper.

AVAILABILITY:

The ORAL·SCREEN™ Saliva Drug Testing System is currently available for point of contact drug of abuse screening in the following configurations. Standard pack is a dispenser box of twenty tests. ORAL·SCREEN™ Saliva Drug Tests are for use in institutional, corporate, professional, judicial, educational and workplace drug testing programs and are intended for non-diagnostic forensic use only. Orders for samples or quantities less than the standard sales units are acceptable under the terms of our sample policy and may be ordered here.

Description	Quantity	Unit	Cost
ORAL·SCREEN™ Saliva 4 Panel Drug Test	Twenty (20) Tests	Dispenser Box	$395.00
	One Hundred (100) Tests	Case	$1,850.00
*If the order buttons are absent or inoperable, please use the pricing overview page to order.